proprietari
oxal
decarboxylas
oxdc
enzym
develop
food
ingredi
studi
safeti
evalu
bacteri
mutagen
assay
subchron
oral
toxic
studi
rat
show
mutagen
properti
mutagen
assay
subchron
oral
toxic
studi
spragu
dawley
rat
per
sex
administ
mgkg
bwday
unitskg
bwday
respect
gavag
male
femal
rat
show
test
articlerel
clinic
observ
effect
bodi
weight
bodi
weight
gain
food
consumpt
food
effici
ophthalmolog
function
observ
batteri
paramet
motor
activ
furthermor
chang
coagul
clinic
chemistri
urinalysi
hematolog
paramet
macroscopicmicroscop
find
organ
weight
could
attribut
test
articl
base
result
mutagen
noadverseeffect
level
noael
studi
determin
mgkg
bwday
unitskg
bwday
evalu
estim
consumpt
gener
metabolit
format
current
safeti
studi
result
conclus
toler
upper
limit
unit
oxdc
activityday
unit
activitykg
bwday
ad
food
decreas
dietari
oxal
oxal
normal
produc
plant
primarili
leav
nut
fruit
bark
content
oxal
high
mani
plant
food
includ
veget
cereal
grain
nut
bean
beverag
exampl
oxal
concentr
g
fresh
spinach
dri
soy
bean
dri
peanut
dri
wheat
bran
mg
mg
mg
mg
respect
massey
daili
oxal
intak
typic
mgday
howev
rang
mgday
individu
eat
typic
western
diet
holm
kennedi
plantbas
food
contain
variou
quantiti
oxal
oxal
content
also
vari
wide
within
plant
speci
due
growth
season
soil
water
condit
massey
holm
kennedi
although
oxal
catabol
bacteria
fungi
plant
human
produc
enzym
degrad
oxal
chakraborti
et
al
oxal
aciddegrad
bacteria
found
fece
human
abratt
reid
howev
extent
degrad
oxal
acid
gastrointestin
gi
tract
human
either
unknown
inconclus
one
gut
bacteria
investig
therapeut
oxalobact
formigen
organ
use
oxal
major
energi
carbon
sourc
anywher
ingest
oxal
absorb
human
depend
sourc
dose
state
fed
fast
noonan
savag
oxal
known
chelat
agent
metal
cation
dietari
oxal
may
form
magnesium
iron
calcium
salt
food
gi
tract
asplin
israr
et
al
consequ
unabsorb
oxal
form
salt
aforement
miner
gi
tract
promot
miner
excret
fece
reduc
potenti
essenti
miner
absorpt
noonan
savag
oxal
may
absorb
throughout
entir
gi
tract
begin
stomach
hautmann
chen
et
al
concentr
oxal
serum
human
consum
typic
western
diet
mm
much
lower
satur
concentr
porowski
et
al
howev
due
water
reabsorpt
kidney
oxal
concentr
urin
increas
time
usual
rang
mm
sakhae
urinari
calcium
concentr
normal
time
oxal
concentr
pak
et
al
therefor
urinari
calcium
oxal
often
supersatur
usual
describ
supersatur
ratio
number
approxim
ratio
salt
concentr
urin
solubl
salt
concentr
solut
higher
solubl
salt
start
precipit
certain
concentr
call
upper
limit
metast
coe
et
al
upper
limit
calcium
oxal
metast
vari
urin
condit
ion
macromolecul
urin
ph
reduc
oxal
andor
increas
citrat
intak
andor
encourag
least
l
urin
output
per
year
salt
concentr
urin
kept
upper
limit
metast
thu
allow
normal
variat
urin
ion
macromolecul
ph
condit
without
introduc
abnorm
level
calcium
oxal
precipit
format
believ
calcium
oxal
supersatur
lack
hydrat
driver
calcium
oxal
stone
format
although
process
complex
complet
clear
may
involv
sever
critic
factor
includ
urinari
macromolecul
bile
acid
renal
tubular
damag
tsujihata
porowski
et
al
coe
et
al
matlaga
et
al
saso
et
al
typic
strategi
limit
oxal
exposur
dietari
avoid
oxal
increas
calcium
ingest
satur
calciumbind
site
oxal
promot
oxal
excret
liesk
et
al
liesk
et
al
oxal
avoid
difficult
oxal
present
mani
differ
food
level
oxal
singl
food
variabl
holm
kennedi
therefor
challeng
find
food
keep
oxal
ingest
low
without
compromis
nutrit
balanc
bong
cowork
recent
demonstr
calcium
chlorid
success
remov
signific
portion
solubl
oxal
process
spinach
bong
et
al
herein
enzym
approach
present
effect
reducingremov
solubl
insolubl
oxal
varieti
food
beverag
oxal
decarboxylas
oxal
metabol
enzym
requir
catalyt
amount
oxygen
convert
oxal
format
carbon
dioxid
found
bacteria
fungi
screen
thousand
homolog
oxal
decarboxylas
discov
ideal
properti
degrad
oxal
food
wide
ph
rang
includ
acid
ph
stomach
order
use
food
ingredi
import
show
particular
enzym
safe
consum
therefor
vitro
bacteri
mutagen
studi
week
subchron
rat
studi
conduct
evalu
potenti
toxic
studi
perform
accord
oecd
principl
follow
good
laboratori
practic
glp
ident
properti
manufactur
ident
highli
solubl
gl
manganesecontain
trimer
oxal
decarboxylas
oxdc
enzym
singl
subunit
molecular
weight
kda
determin
electrospray
ioniz
mass
spectrometri
esim
enzym
demonstr
absolut
specif
oxal
demonstr
absenc
activ
carboxyl
acid
similar
structur
oxam
phthalic
furmar
glutar
formic
acet
oxaloacet
malic
citric
glycol
succin
malon
pyruv
acid
furthermor
enzym
high
melt
point
c
activ
wide
ph
rang
optim
activ
ph
c
mmolminmg
use
clustal
softwar
multipl
sequenc
align
comparison
wildtyp
oxdc
gene
synechoccu
elong
gene
express
escherichia
coli
conduct
larkin
et
al
although
codon
usag
optim
gene
express
e
coli
amino
acid
sequenc
encod
protein
ident
method
manufactur
raw
materi
raw
materi
use
ferment
recoveri
process
includ
deminer
water
yeast
extract
pepton
miner
includ
manganes
chlorid
ph
regul
kanamycin
sugarbas
carbon
sourc
antifoam
aid
standard
ingredi
use
enzym
industri
antifoam
addit
use
accord
enzym
technic
associ
submiss
fda
antifoam
floccul
date
april
maximum
use
level
antifoam
use
product
less
cell
line
oxdc
gene
synthes
use
dna
sequenc
inform
gene
encod
oxdc
synechoccu
elong
avail
ncbi
genebank
nativ
full
length
gene
codonoptim
e
coli
express
codonoptim
gene
insert
express
plasmid
transform
e
coli
origin
sourc
organ
e
coli
nonpathogen
strain
long
histori
safe
use
oecd
epa
sourc
oxdc
gene
templat
synechococcu
elong
pcc
categor
biosafeti
level
organ
joint
genom
institut
organ
recogn
caus
diseas
adult
human
sinc
gene
produc
synthet
risk
transfer
unknown
pathogen
toxicogen
determin
synechococcu
elong
human
ferment
purif
dri
product
origin
pure
cultur
submerg
fedbatch
ferment
nonpathogen
e
coli
carri
express
plasmid
manganes
chlorid
ad
process
ensur
express
activ
enzym
equip
care
design
construct
oper
clean
maintain
prevent
contamin
foreign
microorgan
step
ferment
physic
chemic
control
measur
taken
ensur
absenc
foreign
microorgan
confirm
strain
ident
recoveri
process
multistep
oper
design
separ
desir
enzym
microbi
biomass
partial
purifi
concentr
stabil
enzym
follow
ferment
enzym
first
liber
product
strain
cell
disrupt
homogen
biomass
treat
buffer
solut
residu
solid
remov
seri
sediment
filtrat
process
design
remov
debri
greater
molecular
weight
nucleas
ad
remov
remain
remnant
plasmid
dna
result
filtrat
concentr
use
ultrafiltr
diafiltr
final
retent
filter
mm
filter
steril
result
enzym
concentr
test
articl
use
studi
found
herein
appropri
food
grade
specif
establish
see
tabl
specif
consist
puriti
microbi
limit
establish
enzym
prepar
fcc
edit
joint
faowho
expert
committe
food
addit
jecfa
jecfa
fcc
method
analysi
util
intern
recogn
valid
see
tabl
specif
act
oxal
convert
oxal
format
carbon
dioxid
prepar
ad
food
order
remov
avail
oxal
demonstr
enzym
effect
varieti
juic
beer
can
food
analyz
oxal
content
abil
extract
degrad
oxal
liquid
foodsbeverag
test
ad
variou
concentr
incub
c
three
hour
solid
food
first
resuspend
prior
ad
sampl
analyz
use
dionex
ic
system
ion
chromatographi
column
use
potassium
hydroxid
eluent
kaviraj
et
al
studi
design
mutagen
averag
activ
unitsmg
evalu
measur
abil
induc
revers
mutat
salmonella
typhimurium
strain
ta
ta
escherichia
coli
strain
uvra
purchas
molecular
toxicolog
inc
boon
nc
assay
plate
incorpor
preincub
conduct
presenc
absenc
metabol
activ
mix
prepar
microsom
fraction
rat
liver
microsom
liver
fraction
prepar
male
spraguedawley
rat
induc
phenobarbit
benzoflavon
test
substanc
suspend
mm
arginin
buffer
ph
mix
thoroughli
steril
water
use
vortex
ad
plate
achiev
concentr
mgplate
posit
control
absenc
mix
daunomycin
mgml
typhimurium
sodium
azid
mgml
typhimurium
icr
acridin
mgml
methyl
methanesulfon
mgml
e
coli
posit
control
bacteri
strain
presenc
mix
mgml
neg
control
strain
presenc
absenc
mix
steril
water
sourc
posit
control
mutagen
microsom
liver
fraction
molecular
toxicolog
inc
boon
nc
plate
prepar
triplic
supplement
test
perform
strain
verifi
bacteri
titer
result
studi
consid
posit
increas
mean
number
revert
time
neg
control
valu
strain
time
neg
control
valu
strain
uvra
criteria
valid
normal
appear
bacteri
lawn
substanti
increas
number
revert
coloni
posit
control
mean
revert
coloni
count
vehicl
control
within
laboratori
histor
control
andor
publish
valu
upon
arriv
product
safeti
lab
dayton
new
jersey
anim
individu
hous
suspend
stainless
steel
cage
within
room
maintain
lightdark
cycl
c
rel
humid
litter
paper
place
underneath
cage
chang
least
three
time
per
week
rat
provid
envigo
teklad
certifi
global
rodent
diet
indianapoli
filter
tap
water
ad
libitum
throughout
studi
except
night
termin
food
withdrawn
diet
contain
ppm
oxal
acid
analyz
aoac
offici
method
modifi
anim
weigh
g
male
g
femal
sevenday
acclim
period
approxim
seven
eight
week
age
initi
dose
rat
randomli
distribut
among
three
dose
group
mgkg
bwday
control
group
dose
use
base
result
previou
fourteenday
rat
pilot
studi
mgkg
bwday
use
strain
speci
use
studi
high
dose
consid
practic
dose
testarticl
formul
test
system
serum
sampl
three
anim
hous
studi
anim
part
studi
evalu
absenc
common
rat
pathogen
rat
parvoviru
toolan
viru
kilham
rat
viru
rat
minut
viru
parvoviru
rat
coronaviru
rat
theiloviru
pneumocysti
carinii
last
day
test
period
sentinel
sampl
neg
pathogen
evalu
studi
anim
deem
healthi
reason
free
common
rat
pathogen
dose
solut
prepar
daili
dilut
averag
activ
unitsmg
mm
arginin
ph
produc
dose
solut
solut
stir
ambient
temperatur
visual
homogen
mixtur
achiev
maintain
magnet
stir
plate
dose
administr
solut
administ
rat
via
oral
gavag
dosag
volum
mlkg
bw
provid
dose
mgkg
bwday
unitskg
bwday
respect
control
group
receiv
vehicl
mm
arginin
ph
dose
volum
test
anim
absolut
volum
provid
calcul
base
recent
weekli
bodi
weight
adjust
week
maintain
target
dose
level
rat
dose
approxim
time
day
h
first
studi
activ
day
formul
except
date
hematolog
andor
clinic
chemistri
sampl
collect
day
function
observ
batteri
fob
test
dose
schedul
design
maxim
format
format
ingest
food
rat
eat
night
consum
last
meal
ulman
et
al
homogen
test
sampl
taken
day
top
middl
bottom
dose
contain
prepar
stir
homogen
sampl
also
use
verifi
concentr
day
sampl
collect
concentr
verif
sampl
immedi
frozen
ship
captozym
inc
gainesvil
fl
analysi
homogen
concentr
verif
evalu
use
bradford
assay
bradford
bodi
weight
record
prior
test
initi
weekli
studi
prior
studi
termin
bodi
weight
gain
calcul
select
interv
overal
studi
food
consumpt
record
weekli
food
effici
mean
daili
bodi
weight
gainmean
daili
food
consumpt
calcul
ophthalmolog
evalu
conduct
anim
acclim
prior
test
termin
day
anim
observ
least
twice
daili
mortal
per
day
sign
gross
toxic
detail
clinic
observ
perform
daili
includ
chang
skin
fur
eye
mucou
membran
occurr
secret
excret
autonom
activ
addit
chang
gait
postur
respons
handl
well
presenc
clonic
tonic
movement
stereotypi
bizarr
behavior
also
note
complet
fob
carri
week
administr
rat
examin
random
order
observ
know
treatment
group
rat
belong
fob
includ
numer
home
cage
handl
open
field
sensori
observ
paramet
motor
activ
also
evalu
anim
clinic
patholog
perform
anim
end
dose
phase
blood
sampl
hematolog
clinic
chemistri
collect
via
sublingu
bleed
isofluran
anesthesia
approxim
ml
blood
collect
precalibr
tube
contain
k
edta
hematolog
assess
ml
collect
tube
contain
preserv
clinic
chemistri
sampl
centrifug
refriger
centrifug
result
serum
collect
store
ice
blood
sampl
use
determin
prothrombin
partial
thromboplastin
time
coagul
collect
via
inferior
vena
cava
isofluran
anesthesia
termin
sacrific
approxim
ml
blood
collect
precalibr
tube
contain
sodium
citrat
centrifug
result
plasma
collect
store
c
termin
sacrific
rat
human
euthan
exsanguin
abdomin
aorta
isofluran
anesthesia
urinalysi
includ
color
clariti
specif
graviti
ph
protein
glucos
keton
bilirubin
occult
blood
nitrit
urobilinogen
volum
microscopi
sediment
leukocyt
also
conduct
week
complet
necropsi
conduct
anim
termin
studi
follow
tissu
organ
collect
accessori
genit
organ
adren
aorta
bone
femur
bone
marrow
femur
sternum
brain
medullapon
cerebellar
cerebr
cortex
cecum
cervix
colon
duodenum
epididymid
esophagu
eye
harderian
gland
heart
ileum
peyer
patch
jejunum
kidney
larynx
liver
lung
lymph
node
mandibular
lymph
node
mesenter
mammari
gland
nasal
turbin
nose
optic
nerv
ovari
oviduct
pancrea
parathyroid
peripher
nerv
sciatic
pharynx
pituitari
rectum
salivari
gland
sublingu
submandibular
parotid
skelet
muscl
skin
spinal
cord
cervic
mid
thorac
lumbar
spleen
sternum
stomach
test
thymu
thyroid
trachea
urinari
bladder
uteru
vagina
weight
record
follow
organ
adren
brain
epididymid
heart
kidney
liver
ovari
oviduct
spleen
test
thymu
uteru
tissu
fix
neutral
buffer
formalin
except
eye
includ
optic
nerv
test
fix
modifi
davidson
fix
moor
barr
histopatholog
conduct
anim
control
high
dose
group
hematoxylineosin
stain
paraffin
section
tissu
list
statist
method
bodi
weight
bodi
weight
chang
food
consumpt
organ
weight
evalu
homogen
varianc
normal
bartlett
test
bartlett
bartlett
test
indic
homogen
varianc
treat
control
group
compar
use
oneway
analysi
varianc
anova
oneway
analysi
varianc
signific
p
comparison
treat
group
control
dunnett
test
dunnett
dunnett
multipl
comparison
perform
varianc
consid
significantli
differ
bartlett
test
group
compar
use
kruskalw
nonparametr
analysi
varianc
kruskal
walli
nonparametr
analysi
varianc
signific
comparison
treat
group
control
perform
use
dunn
test
dunn
statist
analysi
perform
quantit
data
inlif
organ
weight
paramet
use
provanti
version
motor
activ
data
analyz
use
twoway
repeat
measur
anova
instat
biostatist
graph
pad
softwar
san
diego
ca
clinic
patholog
result
analyz
use
leven
test
homogen
shapirowilk
test
normal
preliminari
test
signific
oneway
analysi
varianc
perform
follow
dunnett
test
food
test
within
ph
rang
show
activ
tabl
abl
remov
signific
portion
solubl
insolubl
oxal
food
outlin
tabl
induc
signific
dosedepend
increas
number
revert
coloni
strain
test
absenc
presenc
mix
either
experi
tabl
sign
precipit
contamin
note
strain
sign
toxic
observ
e
coli
dose
mgplate
plate
incorpor
preincub
experi
absenc
presenc
evid
decreas
revert
count
microcoloni
format
absenc
lawn
investig
toxic
supplement
test
perform
strain
use
five
addit
dose
level
rang
mgplate
eight
dose
level
without
precipit
plate
contamin
evalu
strain
therefor
bacteri
mutagen
adequ
assess
mean
revert
coloni
count
strain
treat
vehicl
close
within
expect
rang
consid
laboratori
histor
control
rang
andor
publish
valu
mortelman
zeiger
gatehous
posit
control
substanc
caus
expect
substanti
increas
revert
coloni
count
absenc
presenc
phase
test
confirm
sensit
test
activ
mix
therefor
phase
test
consid
valid
test
substanc
determin
stabl
condit
storag
cours
studi
stabl
throughout
durat
studi
determin
activ
sdspage
analysi
homogen
sampl
rsd
combin
concentr
verif
sampl
rsd
base
overal
stabil
homogen
concentr
verif
analysi
anim
consid
receiv
target
dose
concentr
within
accept
margin
variat
mortal
cours
studi
clinic
observ
attribut
oral
administr
clinic
observ
consid
incident
regard
toxicolog
insignific
function
behavior
result
test
group
male
femal
rat
perform
week
consid
compar
control
group
chang
quantit
measur
increas
incid
open
field
measur
minim
associ
constel
find
would
support
toxicolog
signific
behavior
chang
mean
quantit
measur
forelimbhindlimb
grip
strength
hindlimb
foot
splay
compar
control
valu
femal
male
rat
motor
activ
ie
mean
total
movement
result
compar
male
femal
rat
group
data
shown
chang
bodi
weight
bodi
weight
gain
male
femal
rat
attribut
administr
test
substanc
fig
mean
weekli
bodi
weight
mean
daili
bodi
weight
gain
treat
male
rat
compar
control
male
throughout
studi
likewis
mean
daili
bodi
weight
gain
treat
femal
rat
gener
compar
control
femal
throughout
studi
except
statist
signific
decreas
p
mgkg
bwday
group
day
statist
signific
chang
weight
gain
consid
transient
spuriou
natur
incident
regard
toxicolog
insignific
chang
food
consumpt
tabl
food
effici
data
shown
attribut
administr
test
substanc
mean
daili
food
consumpt
mean
food
effici
treat
male
rat
compar
control
male
throughout
studi
likewis
mean
daili
food
consumpt
effici
treat
femal
rat
gener
compar
control
femal
throughout
studi
statist
signific
decreas
p
food
effici
femal
rat
occur
mgkg
bwday
group
day
mgkg
bw
day
group
day
statist
signific
transient
chang
food
effici
consid
spuriou
natur
incident
regard
toxicolog
insignific
chang
hematolog
coagul
tabl
clinic
chemistri
tabl
urinalysi
tabl
paramet
attribut
administr
chang
hematolog
limit
increas
white
blood
cell
count
absolut
lymphocyt
count
femal
rat
mgkg
bwday
group
p
white
blood
cell
count
group
ml
ml
respect
within
histor
rang
laboratori
valu
ml
absolut
lymphocyt
count
ml
ml
respect
also
within
histor
laboratori
rang
valu
ml
chang
white
blood
cell
lymphocyt
count
correl
organ
weight
microscop
observ
thu
interpret
littl
toxicolog
signific
advers
statist
signific
increas
cholesterol
femal
mgkg
bw
dose
judg
toxicolog
relev
observ
middos
valu
within
normal
publish
valu
mgdl
femal
control
spraguedawley
rat
similar
age
lee
et
al
effect
test
materi
organ
weight
mean
absolut
organ
weight
organ
weight
ratio
rel
brain
bodi
weight
treat
anim
gener
compar
control
anim
tabl
statist
signific
differ
includ
increas
p
mid
dose
male
spleentobodi
weight
ratio
decreas
p
high
dose
femal
absolut
brain
weight
nondos
depend
statist
signific
increas
spleentobodi
weight
ratio
measur
day
mid
dose
male
rat
decreas
brain
weight
measur
day
high
dose
femal
rat
administ
without
histolog
correl
directli
correl
studi
paramet
therefor
consid
toxicolog
signific
macroscop
microscop
find
relat
exposur
test
substanc
observ
macroscop
observ
termin
sporad
incid
show
trendspattern
suggest
relationship
administr
two
anim
one
per
sex
given
mgkg
bwday
microscop
observ
involv
esophagu
attribut
gavag
procedur
find
focal
multifoc
mural
necrosi
muscl
associ
chronic
inflamm
addit
one
femal
given
mgkg
bw
day
mammari
gland
adenocarcinoma
thorac
region
consid
incident
neoplasm
unrel
administr
test
substanc
base
occurr
singl
middos
femal
result
report
mean
standard
deviat
statist
signific
differ
control
note
p
proprietari
oxal
decarboxylas
oxdc
enzym
develop
food
ingredi
degrad
oxal
acid
food
reduc
concentr
oxal
avail
caus
antinutrit
toxicolog
effect
order
use
food
must
demonstr
safe
use
show
mutagen
properti
valid
vitro
bacteri
revers
mutat
assay
without
metabol
activ
furthermor
result
oecd
guidelin
toxic
studi
rat
indic
oral
gavag
observ
advers
effect
level
noael
rat
mgkg
bwday
highest
dose
administ
toxic
studi
clinic
observ
chang
ophthalmolog
bodi
weight
bodi
weight
gain
alt
ul
sdh
ul
g
alkp
ul
bili
mgdl
bun
mgdl
crea
mgdl
alb
gdl
glob
gdl
calc
mgdl
iph
mgdl
na
mmoll
result
report
mean
standard
deviat
number
sampl
male
control
mgkg
bwday
mgkg
bwday
mgkg
bwday
sampl
number
equal
analys
perform
due
sampl
hemolysi
g
number
sampl
femal
mgkg
bwday
group
due
invalid
result
one
sampl
group
statist
signific
control
p
alb
albumin
alkp
alkalin
phosphat
alt
alanin
aminotransferas
ast
aspart
aminotransferas
bili
total
bilirubin
bun
urea
nitrogen
calc
calcium
chol
cholesterol
cl
chlorid
crea
creatinin
glob
globulin
gluc
glucos
hco
bicarbon
iph
inorgan
phosphoru
k
potassium
na
sodium
sdh
sorbitol
dehydrogenas
tp
total
protein
trig
triglycerid
food
consumpt
food
effici
fob
motor
activ
attribut
test
materialrel
chang
hematolog
coagul
clinic
chemistri
urinalysi
paramet
chang
hematolog
limit
increas
white
blood
cell
count
absolut
lymphocyt
count
mid
mgkg
bw
day
high
dose
femal
rat
howev
result
achiev
statist
signific
well
within
histor
control
rang
chang
small
magnitud
correl
organ
weight
microscop
observ
thu
hematolog
chang
interpret
littl
toxicolog
signific
advers
macroscop
microscop
find
organ
weight
chang
attribut
administr
sporad
patholog
find
consid
incident
show
trend
pattern
suggest
relationship
administr
observ
similar
rate
spraguedawley
rat
similar
age
gender
germann
et
al
sugimoto
et
al
perci
barthold
mcinn
one
femal
rat
administ
mgkg
bwday
mammari
gland
adenocarcinoma
thorac
region
also
consid
unrel
test
materi
isol
natur
occur
middl
dose
mammari
gland
adenocarcinoma
report
spraguedawley
rat
young
twelv
week
age
kuzutani
et
al
agedepend
frequenc
mammari
adenocarcinoma
find
make
difficult
give
robust
quantit
statement
howev
base
upon
experi
psl
adenocarcinoma
equal
like
observ
control
group
treatment
group
therefor
one
two
adenocarcinoma
treatment
group
consid
test
substancerel
statist
signific
increas
mid
dose
male
spleentobodi
weight
ratio
decreas
high
dose
femal
absolut
brain
weight
correl
histopatholog
clinic
patholog
find
effect
test
materi
test
neurolog
function
recogn
organ
weight
chang
without
macroscop
microscop
correl
necessarili
treatmentrel
advers
seller
et
al
calcul
estim
daili
intak
edi
individu
consum
food
group
select
addit
data
us
depart
agricultur
eat
america
wweia
nation
food
intak
survey
nhane
releas
everi
two
year
one
dataset
use
determin
intak
nhane
dataset
util
two
day
dietari
ph
sg
result
report
mean
standard
deviat
eu
ehrlich
unit
sg
specif
graviti
umtp
protein
uro
urobilinogen
uvol
volum
mean
absolut
organ
weight
organ
rel
bodi
weight
male
n
femal
n
intak
per
respond
day
detail
descript
obtain
amount
type
food
product
consum
food
product
assign
specif
food
code
util
proprietari
comput
program
weight
data
nhane
data
set
evalu
determin
estim
amount
may
consum
ad
select
food
level
specifi
tabl
food
correspond
provid
usda
except
brown
rice
flour
soy
flour
present
nhane
survey
like
type
flour
use
replac
type
flour
diet
eg
wheat
purpos
flour
like
estim
intak
purpos
wheat
flour
encompass
intak
brown
rice
soy
flour
ad
select
food
level
specifi
tabl
ad
mean
percentil
consumpt
estim
mgday
mgkg
bwday
assum
kg
person
mgday
mgkg
bwday
respect
individu
consum
food
product
ie
eater
individu
percentil
intak
level
util
safeti
assess
indic
highlevel
consum
product
may
contain
gender
basi
estim
men
consum
mg
day
mgkg
bwday
women
consum
mgday
mgkg
bwday
percentil
peopl
year
age
estim
consum
higher
level
mean
mgday
mgkg
bwday
percentil
mgday
mgkg
bwday
assum
kg
person
substanc
show
genderor
agespecif
advers
effect
none
assess
evalu
potenti
longterm
chronic
intak
reli
eater
data
percentil
avoid
possibl
underestim
intak
individu
frequent
consum
food
contain
ingredi
base
manganes
content
ppm
amount
manganes
consum
percentil
level
intak
eater
individu
mg
ngkg
bwday
nutrit
insignific
amount
base
optim
activ
unit
mmolmin
mg
ad
mean
percentil
consumpt
term
unit
enzymat
activ
unitsday
unitskg
bwday
unitsday
unitskg
bwday
thu
percentil
consum
addit
food
state
tabl
could
potenti
degrad
mmol
oxal
mg
base
molecular
weight
oxal
gmol
one
minut
enzym
catalyz
degrad
one
mole
oxal
g
one
mole
format
g
base
molecular
weight
format
gmol
g
oxal
g
format
ratio
percentil
consum
food
contain
would
produc
mg
formateday
mgkg
bwday
sourc
high
blood
level
format
thought
respons
optic
nerv
damag
metabol
acidosi
occur
methanol
poison
hallmark
format
toxic
includ
decreas
blood
potassium
bicarbon
hyperpnea
visual
impair
eell
et
al
mahieu
et
al
certifi
harlan
teklad
global
rodent
diet
select
due
high
oxal
content
mg
oxalatekg
diet
assum
oxal
degrad
format
result
exposur
would
mg
formatekg
bwday
male
femal
rat
respect
far
exceed
predict
human
exposur
importantli
effect
blood
potassium
bicarbon
level
clinic
ophthalmolog
behavior
find
suggest
format
toxic
current
accept
daili
intak
adi
formic
acid
acid
format
establish
joint
faowho
expert
committe
food
addit
jecfa
mgkg
bwday
jecfa
food
natur
contain
formic
acid
number
formic
acidcontain
compound
permit
fda
use
food
addit
synthet
flavor
substanc
adjuv
averag
daili
intak
formic
acid
diet
estim
select
committe
gra
substanc
scog
mgkg
bwday
scog
dietari
intak
oxal
previous
estim
mgday
mean
intak
mgday
holm
kennedi
fda
state
estim
percentil
intak
approxim
twice
mean
fda
assum
percentil
intak
oxal
mg
mmole
per
person
mg
mgkg
bwday
format
could
produc
degrad
oxal
consum
use
g
oxal
g
format
ratio
thu
ad
food
level
remov
standard
ident
may
exist
food
prohibit
addit
ingredi
food
identifi
mandat
option
ingredi
standard
therefor
addit
food
standard
ident
exist
would
demand
food
product
name
indic
standard
ident
waiver
standard
obtain
percentil
level
dietari
oxal
approxim
mg
equat
unitsday
unitskg
bwday
mg
kg
bw
format
could
produc
daili
basi
ad
mgkg
bwday
format
could
current
ingest
food
slightli
greater
jecfa
adi
mg
kg
bwday
formic
acid
lower
dose
formic
acid
shown
safe
human
mg
kg
bwday
inchem
although
anticip
amount
consum
addit
food
unitskg
bwday
anticip
unitskg
bwday
safe
consum
base
maximum
amount
format
could
gener
state
kanamycin
use
manufactur
residu
amount
present
base
averag
kanamycin
concentr
ngmg
protein
averag
protein
concentr
mgml
averag
densiti
gml
amount
kanamycin
g
mg
ppm
mean
consumpt
mgday
approxim
ng
day
ngkg
bwday
kanamycin
consum
kanamycin
consumpt
increas
ngday
ngkg
bwday
percentil
level
consumpt
current
regul
regard
permiss
level
kanamycin
food
unit
state
european
agenc
evalu
medicin
product
emea
determin
human
adi
kanamycin
respect
sensit
microorgan
human
gut
flora
peptostreptococcu
mgperson
mgkg
bwday
emea
approxim
time
higher
daili
amount
kanamycin
consum
percentil
consum
therefor
absenc
select
pressur
microbi
growth
risk
develop
antibiot
resist
kanamycin
kanamycin
highli
polar
cation
compound
low
oral
bioavail
approxim
human
emea
thu
amount
kanamycin
absorb
bloodstream
percentil
consum
neglig
expect
bactericid
effect
tissu
fluid
human
bodi
search
publish
literatur
locat
refer
suggest
synechococcu
elong
e
coli
strain
produc
allergen
protein
may
consid
protein
new
human
diet
probabl
allergen
low
base
fact
typic
circumst
exposur
small
number
total
protein
found
food
allergen
known
associ
food
sensit
institut
medicin
nation
research
council
oxdc
enzym
natur
present
diet
bacteria
may
inhabit
larg
intestin
human
without
known
report
allergen
suggest
would
low
potenti
act
allergen
current
scientif
knowledg
suggest
combin
applic
certain
test
provid
reason
assur
protein
low
probabl
act
allergen
tier
test
includ
evalu
whether
sourc
protein
known
allergen
compar
amino
acid
sequenc
protein
known
allergen
epa
faowho
institut
medicin
nation
research
council
delaney
et
al
fao
test
perform
examin
whether
could
consid
allergen
result
studi
discuss
indic
possess
allergen
activ
allergen
onlin
databas
version
access
may
farrp
use
conduct
preliminari
screen
protein
sequenc
relev
match
known
allergen
databas
maintain
food
allergi
research
resourc
program
farrp
univers
nebraska
overal
search
allergen
onlin
conduct
use
default
set
e
cutoff
maximum
align
low
level
match
e
valu
peanut
soybean
protein
share
approxim
ident
identifi
howev
match
share
greater
ident
length
rel
allergen
within
databas
identifi
indic
potenti
crossreact
allergen
low
aalbers
amino
acid
slide
window
segment
etc
use
scan
amino
acid
sequenc
allergen
databas
use
fasta
search
match
ident
ident
amino
acid
segment
suggest
guidelin
propos
codex
evalu
protein
genet
modifi
crop
goodman
et
al
faowho
result
align
possibl
amino
acid
segment
put
allergen
sequenc
databas
less
threshold
amino
acid
addit
sequenc
identifi
exact
match
known
allergen
oxal
decarboxylas
enzym
formul
decreas
oxal
content
certain
process
food
averag
activ
unitsmg
result
studi
describ
manuscript
show
genotox
toxic
spragu
dawley
rat
dose
level
provid
condit
studi
base
toxicolog
endpoint
evalu
noadverseeffect
level
noael
oral
administr
mgkgday
unitskg
bwday
highest
dose
evalu
male
femal
rat
ad
certain
food
decreas
oxal
intak
estim
consum
mgday
percentil
intak
equat
approxim
unitsday
unitskg
bwday
unit
activityday
unit
activitykg
bwday
safe
consum
addit
food
reduc
intak
dietari
oxal
elong
e
coli
strain
use
work
known
produc
allergen
protein
potenti
crossreact
protein
sequenc
known
allergen
low
base
homolog
screen
author
conclud
weight
toxicolog
data
product
support
safeti
substanc
food
ingredi
